Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
about
Evidence of selective reporting bias in hematology journals: A systematic review.Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?Clinical trials: subgroup analyses in randomized trials--more rigour needed.Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.How health equity is reported and analyzed in randomized trials
P2860
Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
@en
type
label
Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
@en
prefLabel
Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
@en
P2093
P356
P1476
Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
@en
P2093
Sheng Zhang
Wenfeng Li
P304
P356
10.1200/JCO.2014.59.8862
P407
P50
P577
2015-04-20T00:00:00Z